moderna covid - Search News

News

Moderna to cut 10% of global workforce

Fox Business on MSN · 2d

Moderna plans to slash 10% of workforce as COVID shot sales slow

Massachusetts-based Moderna said it plans to cut 10% of its global staff as part of its ongoing efforts to reduce annual operating expenses by around $1.5 billion by 2027.

Bloomberg on MSN · 2d

Moderna to Cut 10% of Staff to Offset Slowing Covid Business

Moderna Inc. is cutting about 10% of its workforce, part of an effort by the struggling biotech company to reduce spending as sales of its Covid vaccine decline.

Reuters on MSN · 2d

Moderna plans to lay off 10% of workforce to cut costs

Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of the year, as the biotech accelerates its cost-cutting efforts amid declining sales of COVID-19 vaccines.

Pfizer, Moderna and BioNTech

Reuters on MSN · 1d

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.

Fast Company · 1d

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna’s patents at London’s Court of Appeal.

MarketWatch · 1d

Moderna Says U.K. Court Rules in Favor of its EP'949 Patent, Affirms Infringement by Pfizer and BioNTech

Moderna said a court ruled in favor of one of its patents and that it was infringed on by a competing vaccine. The biotechnology company on Friday said the U.K. Court of Appeal upheld the validity of its EP'949 patent.

1don MSN

Moderna quarterly sales beat Street estimates on COVID booster sales, cost cuts

Moderna topped Wall Street sales expectations and reported a lower-than-expected second-quarter loss on Friday, driven by ...

2d

Moderna Receives European Commission Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

2don MSN

Moderna will lay off 10% of employees, Massachusetts-based company announces

Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...

12h

Moderna to cut more than 800 jobs this year as it burns through cash

In a note to employees on Thursday, Moderna Inc. said it was laying off about 10% of its global workforce as part of the ...

1don MSN

Moderna cuts sales forecast on UK revenue delay, shares fall

Moderna trimmed its 2025 revenue forecast on Friday after UK deliveries of some COVID vaccines were deferred to next year, ...

4d

Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?

MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results